MS News That Caught My Eye Last Week: Stem Cell Trial, COVID-19 Vaccines, MS Blood Test

MS News That Caught My Eye Last Week: Stem Cell Trial, COVID-19 Vaccines, MS Blood Test

312963

MS News That Caught My Eye Last Week: Stem Cell Trial, COVID-19 Vaccines, MS Blood Test

First Patient Dosed in Phase 1 Trial of IMS001 Therapy IMS001 is an investigational treatment that uses mesenchymal stem cells (MSC) — cells derived from human embryos. Preclinical studies have shown that IMS001 has the ability to stabilize an overactive immune system, as is the case in people with MS, as well as repair the blood-brain barrier. These researchers believe IMS001 has the potential to reduce symptom relapses and disease progression, and encourage disease arrest.…

You must be logged in to read/download the full post.